A noninvasive renal fungus ball caused by Rhizopus--a previously unreported manifestation of zygomycosis.
暂无分享,去创建一个
[1] J. Sobel,et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] G. Hasçelik,et al. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. , 2008, Medical mycology.
[3] J. J. B. Sampol. ¿Fungus ball¿ obstructivos en trasplantados renales , 2008 .
[4] J. Dipersio,et al. Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients. , 2007 .
[5] D. Tenen,et al. Significant Role of Peptidyl-Prolyl cis/trans Isomerase, Pin1 in Acute Myeloid Leukemia with C/EBPα Mutations. , 2007 .
[6] W. Croft,et al. Hemorrhagic pulmonary oxalosis secondary to a noninvasive Aspergillus niger fungus ball , 2007, Virchows Archiv.
[7] D. Kontoyiannis,et al. Erratum: Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases (Clinical Infectious Diseases (April 1, 2006) 42 (e61-e65)) , 2006 .
[8] J. Rosenecker,et al. Posaconazole for treatment of refractory invasive fungal disease , 2006, Mycoses.
[9] Ruo-yu Li,et al. Primary renal zygomycosis due to Rhizopus oryzae. , 2006, Medical mycology.
[10] D. Kontoyiannis,et al. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] J. Perfect,et al. Zygomycosis: the re-emerging fungal infection , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[12] M. Schuster,et al. Posaconazole as Salvage Therapy for Zygomycosis , 2006, Antimicrobial Agents and Chemotherapy.
[13] D. Kontoyiannis,et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Russell E. Lewis,et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.
[15] R. Nicholl,et al. Renal fungal ball , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[16] J. Ribes,et al. Zygomycetes in human disease. , 2000, Clinical microbiology reviews.
[17] E. Schick,et al. Primary renal mucormycosis. , 1998, Urology.
[18] P. Govitrapong,et al. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. , 1998, The Journal of pharmacology and experimental therapeutics.
[19] W. Wilson,et al. Successful medical management of isolated renal zygomycosis: case report and review. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] P. Irby,et al. Fungal bezoars of the upper urinary tract. , 1990, The Journal of urology.
[21] O. Ortiz,et al. Percutaneous nephrostomy in the management of renal candidiasis. , 1989, Archives of surgery.
[22] Ballesteros J J Sampol. [Obstructive fungus ball in kidney allografts]. , 2008, Actas urologicas espanolas.